CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Mode of Death in Heart Failure With Preserved Ejection Fraction Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost 稳定性冠心病诊断与治疗指南 Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes?

Original Research2016 Dec;255:73-79.

JOURNAL:Atherosclerosis. Article Link

Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study

Nakanishi R, Ceponiene I, Osawa K et al. Keywords: coronary computed tomography angiography; Diabetes; Plaque progression

ABSTRACT


BACKGROUND AND AIMS - We aimed at investigating whether diabetes is associated with progression in coronary plaque components.

 

METHODS - We identified 142 study subjects undergoing serial coronary computed tomography angiography. The resulting propensity score was applied 1:1 to match diabetic patients to non-diabetic patients for clinical risk factors, prior coronary stenting, coronary arterycalcium (CAC) score and the serial scan interval, resulting in the 71 diabetes and 71 non-diabetes patients. Coronary plaque (total, calcified, non-calcified including fibrous, fibrous-fatty and low attenuation plaque [LAP]) volume normalized by total coronary arterylength was measured using semi-automated plaque software and its change overtime between diabetic and non-diabetic patients was evaluated.

 

RESULTS - The matching was successful without significant differences between the two groups in all matched variables. The baseline volumes in each plaque also did not differ. During a mean scan interval of 3.4 ± 1.8 years, diabetic patients showed a 2-fold greater progression in normalized total plaque volume (TPV) than non-diabetes patients (52.8 mm3vs. 118.3 mm3, p = 0.005). Multivariable linear regression model revealed that diabetes was associated with normalized TPV progression (β 72.3, 95%CI 24.3-120.3). A similar trend was observed for the non-calcified components, but not calcified plaque (β 3.8, 95%CI -27.0-34.7). Higher baseline CAC score was found to be associated with total, non-calcified and calcified plaque progression. However, baseline non-calcified volume but not CAC score was associated with LAP progression.

 

CONCLUSIONS - The current study among matched patients indicates diabetes is associated with a greater plaque progression. Our results show the need for strict adherence of diabetic patients to the current preventive guidelines.

 

Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.